Loading Events

« All Events

  • This event has passed.

Sixth Annual International BioPartnering Conference

May 26, 2016 @ 7:15 am - 5:30 pm

cc57f2f1-b54c-4321-a36c-eb67fc4465ad

Officially approved as part of BioNJ’s Entrepreneurship Program Series

Register_Button

Join us for BioNJ’s 6th Annual International BioPartnering Conference, taking place on Thursday, May 26, 2016 at The Westin Princeton. Bringing together life sciences leaders from New Jersey and beyond, you’ll connect with biotech and pharmaceutical executives, investors, academic research institutions and entrepreneurs who are seeking new business opportunities, licensing agreements and partnerships. Plus, you’ll be able to pre-schedule meetings with other attendees to discuss potential partnership opportunities.

So Much to Do and So Many to Meet…

7:15 a.m. – 8:05 a.m. Registration, Continental Breakfast, Networking & Exhibits
8:05 a.m. – 9:00 a.m.

 

Deal Making in Breakthrough Areas– A Panel Discussion

Angus J. Grant, Ph.D., Corporate Vice President, Business Development, Celgene Corporation; Stephen Hoge, M.D., President, Moderna Therapeutics, Inc.; Reginald Seeto, M.D., Vice President, Head of Partnering and Strategy, MedImmune; Benjamin Thorner, Vice President, Head of North American Innovation Hubs, Merck Research Laboratories
Moderator: Ben Bonifant, Partner, Triangle Insights Group, LLC

This discussion, featuring leading experts in iconic deals, will focus on both sides of the deal with an emphasis on how companies are bringing forward the next generation of therapeutics to patients. Real-life case studies will include the Merck/Moderna deal in the area of mRNA therapeutics and the collaboration between MedImmune and Celgene in the area of PD-L1 immuno-oncology.

9:00 a.m. – 10:30 a.m. Company Presentations & Partnering
10:30 a.m. – 10:50 a.m. Networking Break & Exhibits
10:50 a.m. – 11:25 a.m. Understanding and Accessing Innovation Globally

Robert G. Urban, Ph.D., Global Head, Johnson & Johnson Innovation

Johnson & Johnson Innovation is a model for finding and accessing innovation…literally around the world. During his Keynote presentation, Dr. Robert Urban, Global Head of Johnson & Johnson, will highlight how networks contribute to the development of healthcare solutions.

11:30 a.m. – 12:30 p.m. Company Presentations and Partnering
12:30 p.m. – 1:50 p.m.

 

Luncheon Keynotes:

Driving Towards Transformational Medicines: The Role of Business Development in the Evolution of BMS’ Strategy to Help Patients Prevail Over Serious Diseases

Paul Biondi, SVP, Head of Business Development at Bristol-Myers Squibb, will discuss the evolution of BMS’ strategy and explore the distinct approach the company uses to bring external innovation together with internal efforts to speed transformational medicines to patients in specialty diseases. BMS, through its long and collaborative partnerships, key acquisitions and commitment to work with academic and research centers around the world, is seeking to change the way diseases are treated by dramatically improving on the current standard of care.

Sensemaking in the Era of Digital Health: Applying Theoretical Constructs from Rogers and Wieck to Avoid Becoming the Blockbuster Video of Life Sciences

Dr. Stan Kachnowski, Visiting Professor, Indian Institute of Technology-New Delhi and Chair, Healthcare Innovation Technology Lab (HITLAB), is on the cutting edge of digital health and has a vantage point and a vision to the future that few can tout. Dr. Kachnowski’s presentation promises to provide a practical and entertaining approach to this promising area of development.

1:50 p.m. – 2:10 p.m. Networking Break & Exhibits
2:15 p.m. – 3:45 p.m. Company Presentations & Partnering
3:45 p.m. – 4:40 p.m.

 

De-Risking the Risk: Strategies for Investments in the 2016 Marketplace – A Panel Discussion

Fedora Baloiu, Head, Biopharmaceutical Practice, Houlihan Lokey; Tony Gibney, Managing Director, Leerink Partners; Karen Hong, Ph.D., Managing Director, Parkside Place, LLC; Dennis J. Purcell, Founder and Senior Advisor, Aisling Capital
Moderator: Richard D. Truesdell, Jr., Partner, Davis Polk & Wardell, LLP

It’s all about the money…always has been, always will be. What would a partnering conference be without a panel of experts who can tell us how to access it, what the trends are, how things have changed in recent months, what we can expect for the future….and how we can position ourselves for fundraising success?

4:40 p.m. – 4:50 p.m. Company Presentation Awards
4:50 p.m. – 5:30 p.m. Networking Wine Reception Featuring Israeli and Greek Vintages in the Exhibit Area

Come ready to find new partners, financing and licensing opportunities. Register today. Registration for BioNJ Members is $345 and $495 for Future BioNJ Members.

Please contact Edie Esposito to learn about sponsorship opportunities.

Thank you to our Sponsors.

Ascendia Logo - High Resolution Logo R

BMS blue logo

Dyn Strat Logo

Eisner

Femto_Scientific_Logo

 

fisher_scientific_one

Friedman

blue-black with no border

 

Logo-HighRes

IT_Cadre_Logo_2010

Janssen Pharmaceutical Companies

MERCK

NJ-Business-magazine

General Black and White

stones_throw

Details

Date:
May 26, 2016
Time:
7:15 am - 5:30 pm
Event Category:
Website:
http://bit.ly/1RI9G9S

Venue

The Westin Princeton
201 Village Boulevard
Princeton, NJ 08540 United States
+ Google Map